CD163 and long COVID-19: Robineau et al. [38] also found associations between certain symptoms and biomarkers linked to severity, such as IL-8 and CD163, which play roles in multiorgan dysfunction and infection resolution, suggesting that inflammatory biomarkers may aid in diagnosing PASC in its early phase and in assessing the risk symptom persistence.